Developer docs
API playgroundTry for free, no card

Search company profiles

MMSD

Full company profile

uuid000jv2a

Namestring
MMSD
Legal namestring
Molecular MS Diagnostics, LLC
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Molecular MS Diagnostics (MMSD) is a boutique contract research organization providing analytical, bioanalytical, and strategic product development services to the life sciences industry. Established in 2007, the company operates from a 10,000-square-foot facility in Warwick, Rhode Island, housing three specialized laboratories: GMP Analytical, R&D Bioanalytical, and Cell Culture. MMSD serves pharmaceutical companies, generic drug manufacturers, and biotechnology companies, addressing their need for cost-effective analytical capacity and regulated testing without the capital expenditure of in-house laboratory infrastructure. The legal entity is Molecular MS Diagnostics, LLC, domiciled in Rhode Island.

MMSD's service portfolio spans four primary categories. Analytical Services include assay and impurity HPLC testing, method development, verification and validation, method transfer, photostability testing, dissolution testing, residual solvents analysis (headspace-GC-FID/GC-MS), impurity identification (LC-MS), and heavy metals analysis via ICP-MS. Bioanalytical Services cover plasma and urine drug analysis for small molecules, peptides, and proteins; LC-MS/MS method development; pharmacokinetic profiling (PK parameters, ADME); plasma protein binding screens; P450 screens; hepatocyte induction assays; and tissue analysis. Strategic Product Development provides drug-excipient compatibility, permeation testing, solubility, solid-state characterization, and polymorph screening. Additional offerings include Cell Culture (BioSafety Hood Level II, ELISA, peptide mapping, amino acid analysis, SEC-HPLC-MS/MS, IgG analysis, deformulation, large molecule testing), Counterfeit Drug Analysis, and Extractable and Leachable Testing. The technology stack is anchored on Waters HPLC-2695 with Empower III data acquisition, Sciex 4000Qtrap triple quadrupole mass spectrometers, Agilent ICP-MS for elemental impurities per USP <232>/<233>, UPLC with FL/PDA/MS detection, Agilent 5890 GC with headspace and FID for residual solvents per USP <467>, a Caron photostability chamber with quinine actinometry for ICH Q1B testing, and ICH-controlled stability chambers at 25C/60%RH, 30C/60%RH, and 40C/75%RH.

MMSD operates a project-based contract research revenue model with custom pricing determined by scope, methodology, and turnaround. Sales are conducted through direct enterprise engagement using a single point of contact, with service initiation via downloadable sample submission forms. Pricing is quote-based, billed under project and multi-year contract cadences, and not publicly disclosed. The company is ISO 9001:2015 certified, FDA inspected (GMP compliance), and DEA registered for Class II–V controlled substances, with SOPs, IQ/OQ/PQ documentation, automated environmental monitoring, and a QA-reviewed sample management system. Operations are concentrated in the Northeastern United States. Source data shows no disclosed funding rounds, M&A activity, partnerships, institutional ownership, or geographic expansion beyond the Northeastern US region.

Short descriptiontext

MMSD (Molecular MS Diagnostics) is a boutique contract research organization providing analytical, bioanalytical, and strategic product development services to pharmaceutical, generic drug, and biotechnology firms from its ISO 9001:2015-certified, FDA-inspected, DEA-registered laboratory in Warwick, Rhode Island.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWarwick, United States
HQ citystring
Warwick
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract research services, analytical testing services, bioanalytical method development, pharmaceutical R&D services, stability testing services
Industry3 codes
PRIMARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGADAD
Stability Testing (ICH Programs)
SECONDARYHLAGADAB
Method Development & Validation (ICH/USP)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Medical Laboratories621511
SIC code2 codes
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical Contract Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Services
TypeProfessional Services
Description

MMSD generates revenue through providing analytical and bioanalytical contract research services to pharmaceutical and life sciences companies. Services include method development, validation, testing, and stability studies billed on a project basis.

mmsdiagnostics.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Custom project-based pricing for analytical and bioanalytical services
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing determined by project scope, number of samples, testing methodology, and turnaround time requirements. Sample submission forms available for service requests.

mmsdiagnostics.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

MMSD is a contract research organization providing analytical, bioanalytical, and strategic product development services to pharmaceutical and life sciences companies. Its offerings span assay and impurity HPLC testing, method development and validation, LC-MS/MS bioanalytical assays for plasma and urine, stability testing under ICH conditions, photostability, dissolution testing, residual solvents, heavy metals analysis, cell culture, and counterfeit drug analysis, delivered from an FDA-inspected, ISO 9001:2015 certified, DEA-registered laboratory in Warwick, Rhode Island.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Eliminates time-consuming internal approvals and middlemen through streamlined processes
+2 more records
Product overview1 text field

MMSD (Molecular MS Diagnostics) offers a portfolio of laboratory R&D services for the life sciences industry, organized around three core service lines: Analytical Services (HPLC testing, method development, photostability, dissolution, residual solvents, heavy metals, chiral analysis), Bioanalytical Services (plasma/urine analysis, LC-MS/MS, pharmacokinetic profiling, metabolite identification), and Strategic Product Development (pre-formulation, stability testing, de-formulation). Additional specialized services include Cell Culture, Counterfeit Drug Analysis, and Extractable and Leachable Testing. The company operates as a boutique CRO providing both GLP and non-GLP analytical support, with GMP-compliant testing capabilities.

Product and service5 records
1Analytical Services
CategoryAnalytical Testing Services
Description

Assay and impurity HPLC testing for drug substance and drug products, including method development, verification/validation, method transfer, photostability testing, dissolution testing, residual solvents analysis, ICP-MS heavy metals, FTIR, UV/VIS, Karl Fisher water analysis, and chiral analysis, offered to pharmaceutical companies.

2Bioanalytical Services
CategoryBioanalytical Testing Services
Description

Plasma/blood stability assays; plasma and urine analysis of generic drugs and novel chemical entities (NCEs); LC-MS/MS method development, verification/validation, and method transfer; ADME profiling, pharmacokinetic testing, plasma protein binding screens, hepatocyte induction assays, P450 screens, in-vivo plasma analysis, and tissue analysis, provided to pharmaceutical and biotech clients.

3Strategic Product Development
CategoryProduct Development Consulting
Description

Provides accurate knowledge of unmet need in the product market, planning and management of product development, and effective management of resources and tools, including drug-excipient compatibility, permeation testing, solubility testing and enhancement, solid state characterization, polymorph screening, and photostability testing.

4Cell Culture Services
CategoryCell Culture and Large Molecule Analysis
Description

Biosafety Hood Level II operations, ELISA testing, peptide mapping, amino acid analysis (HPLC/MS/MS), SEC-HPLC-MS/MS, IgG analysis, CEC analysis of proteins, deformulation, and large molecule testing for biotech and pharmaceutical clients.

5Stability Testing
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large full-service CRO now under Thermo Fisher; offers bioanalytical, central lab, and drug-development services that cover the same client engagements MMSD targets, typically at much larger scale.

TypeDirect peer
Description

Mid-sized commercial testing laboratory operating life-sciences and pharmaceutical analytical services similar in style to MMSD, with comparable capacity, instrument footprint, and customer profile.

TypeBroad incumbent
Description

Global testing-services network with significant pharmaceutical analytical and bioanalytical capabilities; competes for the same pharma testing budgets as MMSD via central laboratories and CDMO-adjacent offerings.

TypeBroad incumbent
Description

Largest publicly traded CRO offering comprehensive bioanalytical, DMPK, and stability services to pharma—directly overlapping MMSD's small-molecule and large-molecule testing work, but at vastly greater scale and global reach.

TypeDirect peer
Description

Analytical and materials testing provider for pharma and biotech—mirrors MMSD's combination of method development, impurity ID, and deformulation for drug substance and drug product.

TypeBroad incumbent
Description

Global CRO/CDMO with bioanalytical and DMPK services; increasingly competes for the same small-molecule and biologics bioanalysis work that MMSD serves in the Northeastern US.

TypeBroad incumbent
Description

Pharmaceutical services arm of Intertek offering analytical, stability, extractables/leachables, and biopharma testing—directly comparable menu to MMSD's analytical and strategic product development offerings.

TypeDirect peer
Description

Mid-sized bioanalytical and analytical CRO with comparable LC-MS/MS and small-molecule testing capabilities serving pharmaceutical and generic-drug sponsors; now embedded in a larger CDMO but historically a close peer in size and scope.

TypeDirect peer
Description

Specialized bioanalytical and clinical pharmacology CRO closely aligned with MMSD's LC-MS/MS bioanalysis, PK profiling, and Phase I/ANDA-support work for small molecules.

TypeBroad incumbent
Description

Global testing, inspection, and certification company with pharmaceutical services including analytical chemistry, stability, and extractables/leachables—overlaps substantially with MMSD's compliance-driven testing menu.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MMSD

Pharmaceutical Contract Research Servicesmmsdiagnostics.com

MMSD (Molecular MS Diagnostics) is a boutique contract research organization providing analytical, bioanalytical, and strategic product development services to pharmaceutical, generic drug, and biotechnology firms from its ISO 9001:2015-certified, FDA-inspected, DEA-registered laboratory in Warwick, Rhode Island.

What MMSD does

Molecular MS Diagnostics (MMSD) is a boutique contract research organization providing analytical, bioanalytical, and strategic product development services to the life sciences industry. Established in 2007, the company operates from a 10,000-square-foot facility in Warwick, Rhode Island, housing three specialized laboratories: GMP Analytical, R&D Bioanalytical, and Cell Culture. MMSD serves pharmaceutical companies, generic drug manufacturers, and biotechnology companies, addressing their need for cost-effective analytical capacity and regulated testing without the capital expenditure of in-house laboratory infrastructure. The legal entity is Molecular MS Diagnostics, LLC, domiciled in Rhode Island.

MMSD's service portfolio spans four primary categories. Analytical Services include assay and impurity HPLC testing, method development, verification and validation, method transfer, photostability testing, dissolution testing, residual solvents analysis (headspace-GC-FID/GC-MS), impurity identification (LC-MS), and heavy metals analysis via ICP-MS. Bioanalytical Services cover plasma and urine drug analysis for small molecules, peptides, and proteins; LC-MS/MS method development; pharmacokinetic profiling (PK parameters, ADME); plasma protein binding screens; P450 screens; hepatocyte induction assays; and tissue analysis. Strategic Product Development provides drug-excipient compatibility, permeation testing, solubility, solid-state characterization, and polymorph screening. Additional offerings include Cell Culture (BioSafety Hood Level II, ELISA, peptide mapping, amino acid analysis, SEC-HPLC-MS/MS, IgG analysis, deformulation, large molecule testing), Counterfeit Drug Analysis, and Extractable and Leachable Testing. The technology stack is anchored on Waters HPLC-2695 with Empower III data acquisition, Sciex 4000Qtrap triple quadrupole mass spectrometers, Agilent ICP-MS for elemental impurities per USP <232>/<233>, UPLC with FL/PDA/MS detection, Agilent 5890 GC with headspace and FID for residual solvents per USP <467>, a Caron photostability chamber with quinine actinometry for ICH Q1B testing, and ICH-controlled stability chambers at 25C/60%RH, 30C/60%RH, and 40C/75%RH.

MMSD operates a project-based contract research revenue model with custom pricing determined by scope, methodology, and turnaround. Sales are conducted through direct enterprise engagement using a single point of contact, with service initiation via downloadable sample submission forms. Pricing is quote-based, billed under project and multi-year contract cadences, and not publicly disclosed. The company is ISO 9001:2015 certified, FDA inspected (GMP compliance), and DEA registered for Class II–V controlled substances, with SOPs, IQ/OQ/PQ documentation, automated environmental monitoring, and a QA-reviewed sample management system. Operations are concentrated in the Northeastern United States. Source data shows no disclosed funding rounds, M&A activity, partnerships, institutional ownership, or geographic expansion beyond the Northeastern US region.

MMSD firmographics

Firmographics
Name
MMSD
Legal name
Molecular MS Diagnostics, LLC
Website
https://mmsdiagnostics.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Short description
MMSD (Molecular MS Diagnostics) is a boutique contract research organization providing analytical, bioanalytical, and strategic product development services to pharmaceutical, generic drug, and biotechnology firms from its ISO 9001:2015-certified, FDA-inspected, DEA-registered laboratory in Warwick, Rhode Island.
Ownership category
akta.pro rank

MMSD industry classification

Industry
Product category
Pharmaceutical Contract Research Services
NAICS
Scientific Research and Development Services (5417), Medical Laboratories (621511)
SIC
Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGADAD
Stability Testing (ICH Programs)
SECONDARYHLAGADAB
Method Development & Validation (ICH/USP)

Keywords

  • Contract research services
  • Analytical testing services
  • Bioanalytical method development
  • Pharmaceutical R&D services
  • Stability testing services

Where MMSD is headquartered

Location

Headquarters

HQ city
Warwick
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MMSD business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Contract Research Services: MMSD generates revenue through providing analytical and bioanalytical contract research services to pharmaceutical and life sciences companies. Services include method development, validation, testing, and stability studies billed on a project basis.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing for analytical and bioanalytical services

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

MMSD product offering

Product offering

Core offering

MMSD is a contract research organization providing analytical, bioanalytical, and strategic product development services to pharmaceutical and life sciences companies. Its offerings span assay and impurity HPLC testing, method development and validation, LC-MS/MS bioanalytical assays for plasma and urine, stability testing under ICH conditions, photostability, dissolution testing, residual solvents, heavy metals analysis, cell culture, and counterfeit drug analysis, delivered from an FDA-inspected, ISO 9001:2015 certified, DEA-registered laboratory in Warwick, Rhode Island.

Product overview

MMSD (Molecular MS Diagnostics) offers a portfolio of laboratory R&D services for the life sciences industry, organized around three core service lines: Analytical Services (HPLC testing, method development, photostability, dissolution, residual solvents, heavy metals, chiral analysis), Bioanalytical Services (plasma/urine analysis, LC-MS/MS, pharmacokinetic profiling, metabolite identification), and Strategic Product Development (pre-formulation, stability testing, de-formulation). Additional specialized services include Cell Culture, Counterfeit Drug Analysis, and Extractable and Leachable Testing. The company operates as a boutique CRO providing both GLP and non-GLP analytical support, with GMP-compliant testing capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Analytical Services Assay and impurity HPLC testing for drug substance and drug products, including method development, verification/validation, method transfer, photostability testing, dissolution testing, residual solvents analysis, ICP-MS heavy metals, FTIR, UV/VIS, Karl Fisher water analysis, and chiral analysis, offered to pharmaceutical companies.
  • Bioanalytical Services Plasma/blood stability assays; plasma and urine analysis of generic drugs and novel chemical entities (NCEs); LC-MS/MS method development, verification/validation, and method transfer; ADME profiling, pharmacokinetic testing, plasma protein binding screens, hepatocyte induction assays, P450 screens, in-vivo plasma analysis, and tissue analysis, provided to pharmaceutical and biotech clients.
  • Strategic Product Development Provides accurate knowledge of unmet need in the product market, planning and management of product development, and effective management of resources and tools, including drug-excipient compatibility, permeation testing, solubility testing and enhancement, solid state characterization, polymorph screening, and photostability testing.
  • Cell Culture Services Biosafety Hood Level II operations, ELISA testing, peptide mapping, amino acid analysis (HPLC/MS/MS), SEC-HPLC-MS/MS, IgG analysis, CEC analysis of proteins, deformulation, and large molecule testing for biotech and pharmaceutical clients.
  • Stability Testing

Quantifiable outcome

  • Eliminates time-consuming internal approvals and middlemen through streamlined processes
  • +2 more outcomes

Companies that use MMSD

Customer profile

Segments3 records

Ideal customer profiles3 records

MMSD technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

MMSD partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights3 records

MMSD competitors and assessment

Company assessment

Broad incumbents

  • PPD (Thermo Fisher Scientific): Large full-service CRO now under Thermo Fisher; offers bioanalytical, central lab, and drug-development services that cover the same client engagements MMSD targets, typically at much larger scale.
  • Eurofins Scientific: Global testing-services network with significant pharmaceutical analytical and bioanalytical capabilities; competes for the same pharma testing budgets as MMSD via central laboratories and CDMO-adjacent offerings.
  • Charles River Laboratories: Largest publicly traded CRO offering comprehensive bioanalytical, DMPK, and stability services to pharma—directly overlapping MMSD's small-molecule and large-molecule testing work, but at vastly greater scale and global reach.
  • WuXi AppTec: Global CRO/CDMO with bioanalytical and DMPK services; increasingly competes for the same small-molecule and biologics bioanalysis work that MMSD serves in the Northeastern US.
  • Intertek Pharmaceutical Services: Pharmaceutical services arm of Intertek offering analytical, stability, extractables/leachables, and biopharma testing—directly comparable menu to MMSD's analytical and strategic product development offerings.
  • SGS SA: Global testing, inspection, and certification company with pharmaceutical services including analytical chemistry, stability, and extractables/leachables—overlaps substantially with MMSD's compliance-driven testing menu.

Direct peers

  • Pace Analytical Services: Mid-sized commercial testing laboratory operating life-sciences and pharmaceutical analytical services similar in style to MMSD, with comparable capacity, instrument footprint, and customer profile.
  • EAG Laboratories: Analytical and materials testing provider for pharma and biotech—mirrors MMSD's combination of method development, impurity ID, and deformulation for drug substance and drug product.
  • ABC Laboratories (now part of Curia): Mid-sized bioanalytical and analytical CRO with comparable LC-MS/MS and small-molecule testing capabilities serving pharmaceutical and generic-drug sponsors; now embedded in a larger CDMO but historically a close peer in size and scope.
  • Celerion: Specialized bioanalytical and clinical pharmacology CRO closely aligned with MMSD's LC-MS/MS bioanalysis, PK profiling, and Phase I/ANDA-support work for small molecules.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

MMSD social profiles

Digital presence

MMSD compliance and trust

Trust signal

Compliance3 records

MMSD financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MMSD leadership team

Management profile

Number of profiles

Profiles1 record

MMSD funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MMSD M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MMSD

What does MMSD do?

MMSD is a contract research organization providing analytical, bioanalytical, and strategic product development services to pharmaceutical and life sciences companies. Its offerings span assay and impurity HPLC testing, method development and validation, LC-MS/MS bioanalytical assays for plasma and urine, stability testing under ICH conditions, photostability, dissolution testing, residual solvents, heavy metals analysis, cell culture, and counterfeit drug analysis, delivered from an FDA-inspected, ISO 9001:2015 certified, DEA-registered laboratory in Warwick, Rhode Island.

Is MMSD a public or private company?

MMSD is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MMSD founded?

MMSD was founded in 2007. It employs 1 to 10 people.

Where is MMSD based?

MMSD is headquartered in Warwick, United States, in the North America region.

How does MMSD make money?

One revenue line is on record: contract Research Services.

Who are MMSD's main competitors?

Broad incumbents on record are PPD (Thermo Fisher Scientific), Eurofins Scientific, Charles River Laboratories, WuXi AppTec, Intertek Pharmaceutical Services and SGS SA. Direct peers are Pace Analytical Services, EAG Laboratories, ABC Laboratories (now part of Curia) and Celerion.

Does MMSD have an API?

No public API is recorded for MMSD.

What industry is MMSD in?

MMSD's product category is Pharmaceutical Contract Research Services. Its primary akta.pro industry code is HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity), with a secondary code of HLAGADAD, Stability Testing (ICH Programs). Its NAICS code is 5417 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales